European CHMP recommends license extension of lacosamide (Vimpat) for idiopathic generalised epilepsy
The license extension is for treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
Source:
European Medicines Agency